Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
BMJ
    August 2021
  1. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    >> Share

    June 2021
  2. BURNS TC, Quinones-Hinojosa A
    Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver?
    BMJ. 2021;373:n955.
    >> Share

  3. VALGIMIGLI M, Gragnano F, Branca M, Franzone A, et al
    P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
    BMJ. 2021;373:n1332.
    >> Share

  4. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    >> Share

    May 2021
  5. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
    Atrial fibrillation: diagnosis and management-summary of NICE guidance.
    BMJ. 2021;373:n1150.
    >> Share

  6. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    >> Share

    April 2021
  7. PONAMGI SP, Siontis KC, Rushlow DR, Graff-Radford J, et al
    Screening and management of atrial fibrillation in primary care.
    BMJ. 2021;373:n379.
    >> Share

  8. WOOD A, Denholm R, Hollings S, Cooper J, et al
    Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
    BMJ. 2021;373:n826.
    >> Share

    February 2021

  9. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
    BMJ. 2021;372:n453.
    >> Share

  10. PERRY JJ, Sivilotti MLA, Emond M, Stiell IG, et al
    Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
    BMJ. 2021;372:n49.
    >> Share

    October 2020
  11. WANG DZ, Schwamm LH, Qian T, Dai Q, et al
    Decoding the brain through research-the future of brain health.
    BMJ. 2020;371:m3735.
    >> Share

    September 2020
  12. FILION KB, Lix LM, Yu OH, Dell'Aniello S, et al
    Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
    BMJ. 2020;370:m3342.
    >> Share

    July 2020
  13. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    >> Share

    April 2020
  14. MARKLUND M, Singh G, Greer R, Cudhea F, et al
    Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study.
    BMJ. 2020;369:m824.
    >> Share

    March 2020
  15. COOK R, Davidson P, Martin R
    Computerised speech and language therapy can help people with aphasia find words following a stroke.
    BMJ. 2020;368:m520.
    >> Share

    February 2020
  16. PHIPPS MS, Cronin CA
    Management of acute ischemic stroke.
    BMJ. 2020;368:l6983.
    >> Share

    December 2019
  17. TIAN Y, Liu H, Wu Y, Si Y, et al
    Association between ambient fine particulate pollution and hospital admissions for cause specific cardiovascular disease: time series study in 184 major Chinese cities.
    BMJ. 2019;367:l6572.
    >> Share

  18. HUANG K, Liang F, Yang X, Liu F, et al
    Long term exposure to ambient fine particulate matter and incidence of stroke: prospective cohort study from the China-PAR project.
    BMJ. 2019;367:l6720.
    >> Share

    November 2019
  19. PAPANICOLAS I, Mossialos E, Gundersen A, Woskie L, et al
    Performance of UK National Health Service compared with other high income countries: observational study.
    BMJ. 2019;367:l6326.
    >> Share

  20. MCKENNA-BARRY MT, Ryan JD
    Studies on non-alcoholic fatty liver disease should stratify by disease severity.
    BMJ. 2019;367:l6495.
    >> Share

  21. SATTAR N, Alazawi W
    Authors' reply to McKenna-Barry and Ryan.
    BMJ. 2019;367:l6549.
    >> Share

    October 2019
  22. ALEXANDER M, Loomis AK, van der Lei J, Duarte-Salles T, et al
    Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    BMJ. 2019;367:l5367.
    >> Share

    September 2019
  23. KIM NH, Han KH, Choi J, Lee J, et al
    Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study.
    BMJ. 2019;366:l5125.
    >> Share

  24. NAVE AH, Rackoll T, Grittner U, Blasing H, et al
    Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial.
    BMJ. 2019;366:l5101.
    >> Share

  25. KASKI D, Agarwal K, Murdin L
    Acute vertigo.
    BMJ. 2019;366:l5215.
    >> Share

  26. TONG TYN, Appleby PN, Bradbury KE, Perez-Cornago A, et al
    Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study.
    BMJ. 2019;366:l4897.
    >> Share

  27. LAWRENCE MA, McNaughton SA
    Vegetarian diets and health.
    BMJ. 2019;366:l5272.
    >> Share

    August 2019
  28. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    >> Share

    July 2019

  29. Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults.
    BMJ. 2019;366:l4934.
    >> Share

    June 2019
  30. ROY MP
    Stroke burden in India and strategies for mitigation.
    BMJ. 2019;365:l4243.
    >> Share

  31. WANG Y, Chen W, Lin Y, Meng X, et al
    Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    BMJ. 2019;365:l2211.
    >> Share

    May 2019
  32. SEMINOG OO, Scarborough P, Wright FL, Rayner M, et al
    Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults.
    BMJ. 2019;365:l1778.
    >> Share

  33. MA H, Li X, Sun D, Zhou T, et al
    Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.
    BMJ. 2019;365:l1628.
    >> Share

    April 2019

  34. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.
    BMJ. 2019;365:l1658.
    >> Share

    February 2019
  35. WANG Y, Johnston SC, Bath PM, Grotta JC, et al
    Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.
    BMJ. 2019;364:l895.
    >> Share

  36. LI Z, Jiang Y, Li H, Xian Y, et al
    China's response to the rising stroke burden.
    BMJ. 2019;364:l879.
    >> Share

  37. LOWN M, Moran P
    Should we screen for atrial fibrillation?
    BMJ. 2019;364:l43.
    >> Share

  38. AGARWAL A, Ioannidis JPA
    PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?
    BMJ. 2019;364:l341.
    >> Share

    January 2019
  39. MORRIS S, Ramsay AIG, Boaden RJ, Hunter RM, et al
    Impact and sustainability of centralising acute stroke services in English metropolitan areas: retrospective analysis of hospital episode statistics and stroke national audit data.
    BMJ. 2019;364:l1.
    >> Share


  40. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
    BMJ. 2019;364:l103.
    >> Share

    December 2018
  41. PRASAD K, Siemieniuk R, Hao Q, Guyatt G, et al
    Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
    BMJ. 2018;363:k5130.
    >> Share

  42. HAO Q, Tampi M, O'Donnell M, Foroutan F, et al
    Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
    BMJ. 2018;363:k5108.
    >> Share

    November 2018
  43. MAYOR S
    Thrombectomy can be considered up to 24 hours after onset of stroke, says NICE.
    BMJ. 2018;363:k4995.
    >> Share

    October 2018
  44. CHEN R, Yin P, Wang L, Liu C, et al
    Association between ambient temperature and mortality risk and burden: time series study in 272 main Chinese cities.
    BMJ. 2018;363:k4306.
    >> Share

  45. RUTTEN-JACOBS LC, Larsson SC, Malik R, Rannikmae K, et al
    Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants.
    BMJ. 2018;363:k4168.
    >> Share

  46. SIEMIENIUK RAC, Chu DK, Kim LH, Guell-Rous MR, et al
    Oxygen therapy for acutely ill medical patients: a clinical practice guideline.
    BMJ. 2018;363:k4169.
    >> Share

    September 2018
  47. NISHIKAWA G, Prasad V
    Diagnostic expansion in clinical trials: myocardial infarction, stroke, cancer recurrence, and metastases may not be the hard endpoints you thought they were.
    BMJ. 2018;362:k3783.
    >> Share

  48. SCHMIDT M, Sorensen HT, Pedersen L
    Diclofenac use and cardiovascular risks: series of nationwide cohort studies.
    BMJ. 2018;362:k3426.
    >> Share

    July 2018
  49. KUIJPERS T, Spencer FA, Siemieniuk RAC, Vandvik PO, et al
    Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.
    BMJ. 2018;362:k2515.
    >> Share

  50. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    >> Share

  51. VINOGRADOVA Y, Coupland C, Hill T, Hippisley-Cox J, et al
    Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.
    BMJ. 2018;362:k2505.
    >> Share

    May 2018
  52. RICCI C, Wood A, Muller D, Gunter MJ, et al
    Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study.
    BMJ. 2018;361:k934.
    >> Share

  53. ADDERLEY NJ, Nirantharakumar K, Marshall T
    Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
    BMJ. 2018;361:k1717.
    >> Share

    April 2018
  54. BANERJEE G, Stone SP, Werring DJ
    Posterior circulation ischaemic stroke.
    BMJ. 2018;361:k1185.
    >> Share

    March 2018
  55. JANSEN IGH, Mulder MJHL, Goldhoorn RB
    Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry).
    BMJ. 2018;360:k949.
    >> Share

    February 2018
  56. KUMAR S, de Lusignan S, McGovern A, Correa A, et al
    Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    BMJ. 2018;360:k342.
    >> Share

    January 2018
  57. ADELBORG K, Szepligeti SK, Holland-Bill L, Ehrenstein V, et al
    Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    BMJ. 2018;360:k96.
    >> Share

  58. HACKSHAW A, Morris JK, Boniface S, Tang JL, et al
    Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.
    BMJ. 2018;360:j5855.
    >> Share

    November 2017
  59. LOPEZ-LOPEZ JA, Sterne JAC, Thom HHZ, Higgins JPT, et al
    Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5058.
    >> Share

  60. BALL J
    Which anticoagulant for stroke prevention in atrial fibrillation?
    BMJ. 2017;359:j5399.
    >> Share

    May 2017
  61. MERINO JG
    Selecting patients for endovascular treatment of acute stroke.
    BMJ. 2017;357:j2059.
    >> Share

  62. VENEMA E, Mulder MJHL, Roozenbeek B, Broderick JP, et al
    Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials.
    BMJ. 2017;357:j1710.
    >> Share

    April 2017
  63. GULLAND A
    NHS thrombectomy plan needs more doctors, say stroke experts.
    BMJ. 2017;357:j1861.
    >> Share

  64. MAYOR S
    Ischaemic stroke in younger adults is increasing, US study finds.
    BMJ. 2017;357:j1815.
    >> Share

  65. HAWKES N
    The BMJ Awards 2017: Education.
    BMJ. 2017;357:j1720.
    >> Share

    March 2017
  66. BELL S, Daskalopoulou M, Rapsomaniki E, George J, et al
    Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.
    BMJ. 2017;356:j909.
    >> Share

  67. WISE J
    History of migraine may indicate risk of ischaemic stroke.
    BMJ. 2017;356:j1193.
    >> Share

    February 2017
  68. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2017;356:j510.
    >> Share

    January 2017
  69. TOWERS J
    Lindsey Dow.
    BMJ. 2017;356:j150.
    >> Share

  70. TIMM FP, Houle TT, Grabitz SD, Lihn AL, et al
    Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study.
    BMJ. 2017;356:i6635.
    >> Share

    November 2016
  71. GULLAND A
    RCP warns over shortage of stroke physicians.
    BMJ. 2016;355:i6398.
    >> Share

  72. WALLACH JD, Sullivan PG, Trepanowski JF, Steyerberg EW, et al
    Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses.
    BMJ. 2016;355:i5826.
    >> Share

  73. MAYOR S
    Moderate alcohol intake is linked to lower risk of ischaemic stroke, study finds.
    BMJ. 2016;355:i6339.
    >> Share

  74. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.
    >> Share

  75. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    >> Share

    October 2016

  76. Poor adherence to antihypertensive drugs.
    BMJ. 2016;355:i5606.
    >> Share

  77. TORJESEN I
    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.
    >> Share

    September 2016
  78. JOHNSON LR
    Current physical activity guidance is misinterpreted.
    BMJ. 2016;354:i4811.
    >> Share

    August 2016
  79. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.
    >> Share

    June 2016
  80. DYER O
    Egyptian prosecutors investigate the death of a girl during female genital mutilation.
    BMJ. 2016;353:i3133.
    >> Share

    January 2016
  81. WEILL A, Dalichampt M, Raguideau F, Ricordeau P, et al
    Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    BMJ. 2016;353:i2002.
    >> Share

  82. MAYOR S
    Risk of stroke after transient ischaemic attack is lower than previously thought, study finds.
    BMJ. 2016;353:i2320.
    >> Share

  83. MAYOR S
    Air pollution is a leading risk factor for stroke, global study shows.
    BMJ. 2016;353:i3272.
    >> Share

  84. TIMMIS A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, et al
    Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
    BMJ. 2016;353:i3163.
    >> Share

  85. LARSEN TB, Skjoth F, Nielsen PB, Kjaeldgaard JN, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2016;353:i3189.
    >> Share

  86. JASPERS FOCKS J, Brouwer MA, Wojdyla DM, Thomas L, et al
    Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
    BMJ. 2016;353:i2868.
    >> Share

  87. LI L, Rothwell PM
    Biases in detection of apparent "weekend effect" on outcome with administrative coding data: population based study of stroke.
    BMJ. 2016;353:i2648.
    >> Share

  88. MAYOR S
    Older people with anaemia have higher mortality after stroke, finds study.
    BMJ. 2016;354:i4577.
    >> Share

  89. KYU HH, Bachman VF, Alexander LT, Mumford JE, et al
    Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013.
    BMJ. 2016;354:i3857.
    >> Share

  90. ADAMSSON ERYD S, Gudbjornsdottir S, Manhem K, Rosengren A, et al
    Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    BMJ. 2016;354:i4070.
    >> Share

  91. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016